Table 1. Characteristics of patients positive for HLA-B*57 or HLA-B*58:01 and the Gag sequences analyzed.
| Sequences | ||||||||
| Patient | Seroconversion (S) or HIV+ Entry (E) date | HLA A alleles | HLA B alleles | Δ32 CCR5 genotype | Time after seroconversion or study entry (months) | Number of sequences | ||
| L5 | 06-11-1984 (E) | A*26 | A*68:01 | B*57 | B*07:02 | Wild type | 89 | 6 |
| 177 | 6 | |||||||
| L6 | 09-02-1988 (E) | A3 | A11 | B*58:01 | B7 | Heterozygous | 17 | 5 |
| 114 | 15 | |||||||
| L7 | 03-12-1984 (E) | A*01 | A*02 | B*57:01 | B*050:1 | Heterozygous | 26 | 5 |
| 78 | 6 | |||||||
| 102 | 8 | |||||||
| 136 | 12 | |||||||
| L8 | 06-02-1990 (S) | A*02 | A*02 | B*57:01 | B*37:01 | Wild type | 70 | 2 |
| 91 | 9 | |||||||
| 137 | 6 | |||||||
| L9 | 04-10-1985 (S) | A*01 | A*68:02 | B*57:01 | B*14:02 | Wild type | 42 | 1 |
| 59 | 1 | |||||||
| 77 | 6 | |||||||
| P9 | 20-01-1985 (E) | A2 | A3 | B*57:01 | B*07:02 | Wild type | 9 | 8 |
| 78 | 3 | |||||||
| P10 | 01-01-1984 (E) | A*02 | A*26 | B*57:01 | B*41:02 | Wild type | 69 | 7 |
| 84 | 7 | |||||||
| 123 | 9 | |||||||
| P11 | 15-05-1990 (S) | A1 | A11 | B*57:01 | B*08:01 | Wild type | 3 | 2 |
| 25 | 9 | |||||||
| 32 | 23 | |||||||
| 69 | 13 | |||||||
| P12 | 24-08-1992 (E) | A*01 | A*26 | B*57:01 | B*38:01 | Wild type | 0.4 | 5 |
| 48 | 11 | |||||||
| 74 | 12 | |||||||
| P13 | 22-01-1985 (E) | A*01 | A*01 | B*57:01 | B*08:01 | Wild type | 3 | 6 |
| 46 | 10 |
L: long term non-progressor; P: progressor. S: date of seroconversion for HIV-1 antibodies during active follow-up in the cohort. E: HIV+ entry into the cohort.